Intelligence · Clinical Development
Pipeline search results
Programs matching “ibuprofen” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 21 pipeline programs matching "ibuprofen" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
600 mg Ibuprofen
United Therapeutics Europe Ltd
Tibial Fractures
1 trial -
Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Fever
2 trials -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Postoperative Pain
1 trial -
Intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Tonsillectomy
1 trial -
Paracetamol/Ibuprofen Vale 1000 mg/300 mg oldatos infúzió
Lacuna Pharma Pty Ltd
Acute pain
1 trial -
Ibuprofen
United Therapeutics Europe Ltd
Tonsillectomy
1 trial -
Ibuprofen-PC
Protalix BioTherapeutics
Osteoarthritis
1 trial -
iv ibuprofen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Extremely Premature Infants
1 trial -
Ibuprofen
United Therapeutics Europe Ltd
Tonsillectomy With or Without Adenoidectomy
1 trial -
Ibuprofen 800 mg
United Therapeutics Europe Ltd
Bone Resorption
1 trial -
IV Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Chronic Pelvic Pain
1 trial -
IV ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
1 trial -
IV ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Arthroscopic Knee Surgery
1 trial -
Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
1 trial -
Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Ductus Arteriosus, Patent
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Fever
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Obesity
1 trial -
Intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
3 trials -
Ibuprofen
United Therapeutics Europe Ltd
Immune System and Related Disorders
1 trial -
Indomethacin and Ibuprofen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ductus Arteriosus, Patent
1 trial -
Single dose of ibuprofen (800 mg tablet)
BRIGHT MINDS BIOSCIENCES INC.
Human Gastrointestinal Physiology Data
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.